AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

RESMED INC Director's Dealing 2018

Jan 25, 2018

30071_dirs_2018-01-25_7f28d9b0-1ca6-42c9-a321-e2b6da6f60b4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2018-01-24

Reporting Person: TAYLOR RONALD R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-24	ResMed Common Stock	S	4885	$99.71	Disposed	21751	Direct

Footnotes

F1: This transaction was executed in multiple trades at prices ranging from $99.43 to $99.90. The price reported above reflects the weighted average sale price.